Explorer les evidences

Palier Gold : evidences validées mécaniquement, avec leur source primaire.

7 evidences · page 1 / 1

4,3 %HCV prevalence was 4.3% among HIV-1-infected patients in the IeDEA HIV-2 West Africa cohort surveyed from March to December 2012.

Côte d'Ivoirehépatite C · VIH/sidaobservé March to December 2012publié 2018Journal of public health in Africaeurope_pmcdocument de 9 observations

3,7 %HCV prevalence was 3.7% among HIV-2-infected patients in the IeDEA HIV-2 West Africa cohort surveyed from March to December 2012.

Côte d'Ivoirehépatite C · VIH/sidaobservé March to December 2012publié 2018Journal of public health in Africaeurope_pmcdocument de 9 observations

3,9 %HCV prevalence was 3.9% among HIV-infected adult patients in the IeDEA HIV-2 West Africa cohort surveyed from March to December 2012.

Côte d'Ivoirehépatite C · VIH/sidaobservé March to December 2012publié 2018Journal of public health in Africaeurope_pmcdocument de 9 observations

70 %Detectable HCV RNA was identified in 70.0% of anti-HCV positive patients in the IeDEA HIV-2 West Africa cohort surveyed from March to December 2012.

Côte d'Ivoirehépatite C · VIH/sidaobservé March to December 2012publié 2018Journal of public health in Africaeurope_pmcdocument de 9 observations

100 %Detectable HCV RNA was identified in 100% of anti-HCV positive HIV-1-infected patients in the IeDEA HIV-2 West Africa cohort surveyed from March to December 2012.

Côte d'Ivoirehépatite C · VIH/sidaobservé March to December 2012publié 2018Journal of public health in Africaeurope_pmcdocument de 9 observations

43,8 %Detectable HCV RNA was identified in 43.8% of anti-HCV positive HIV-2-infected patients in the IeDEA HIV-2 West Africa cohort surveyed from March to December 2012.

Côte d'Ivoirehépatite C · VIH/sidaobservé March to December 2012publié 2018Journal of public health in Africaeurope_pmcdocument de 9 observations

4 %HCV prevalence was 4.0% among HIV-1&2 dually reactive patients in the IeDEA HIV-2 West Africa cohort surveyed from March to December 2012.

Côte d'Ivoirehépatite C · VIH/sidaobservé March to December 2012publié 2018Journal of public health in Africaeurope_pmcdocument de 9 observations

Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.